Crawford Lake Capital Management, LLC Sage Therapeutics, Inc. Transaction History

Crawford Lake Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $1.75 Million - $2.98 Million	-21,297 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $11.3 Million - $13.8 Million	-81,919 Reduced 79.37%	21,297 $3.01 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $7.35 Million - $9.2 Million	-52,345 Reduced 33.65%	103,216 $16.2 Million
Q1 2018 May 14, 2018	BUY	$152.15 - $192.33 $195,208 - $246,759	1,283 Added 0.83%	155,561 $25.1 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $9.37 Million - $25.8 Million	154,278	154,278 $25.4 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.